Related Experiment Video
Updated: Feb 11, 2026

Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
Kawasaki Disease and Chlamydia Pneumoniae Infection
1Department of Pediatrics, Sapporo Medical University, Sapporo, Japan.
Insights
Chlamydia pneumoniae infections may play a role in Kawasaki disease. This study found higher levels of IgM antibodies to C. pneumoniae in children with acute Kawasaki disease compared to healthy controls.
Area of Science:
- Infectious Diseases
- Pediatric Cardiology
- Immunology
Background:
- Chlamydia pneumoniae infections are linked to coronary artery disease.
- Kawasaki disease, a pediatric condition primarily affecting children under 5, is associated with coronary artery disease, but its cause remains unknown.
Purpose of the Study:
- To investigate the potential role of Chlamydia pneumoniae in the etiology of Kawasaki disease.
- To assess the prevalence of Chlamydia pneumoniae antibodies in children with active Kawasaki disease.
Main Methods:
- Serum samples were collected from 72 infants and children during the febrile phase of Kawasaki disease.
- Samples were tested for IgG, IgA, and IgM antibodies against Chlamydia pneumoniae.
- Results were compared to age-matched healthy controls.
Main Results:
- 37.5% of patients had IgG antibodies, 30.6% had IgA antibodies, and 15.3% had IgM antibodies to C. pneumoniae.
- The presence of IgM antibodies to C. pneumoniae was significantly higher in children with acute Kawasaki disease than in healthy controls (P<0.01).
Conclusions:
- The findings suggest a potential association between Chlamydia pneumoniae infection and Kawasaki disease.
- Elevated IgM antibodies indicate a possible acute or recent infection contributing to the disease process in pediatric patients.
Abstract:
Chlamydia pneumoniae infections have been associated with coronary artery disease. Although Kawasaki disease is characterized by an association with coronary artery disease in children predominantly under the age of 5, the etiology is still unknown. Serum samples were obtained from 72 infants and children, aged 5 months to 7 years, in the active febrile phase of Kawasaki disease and tested for the presence of C. pneumoniae serum antibodies. Twenty-seven (37.5%) serum samples were positive for an IgG antibody, 22 (30.6%) were positive for an IgA antibody, and 11 (15.3%) were positive for an IgM antibody to C. pneumoniae. The presence of serum IgM antibodies to C. pneumoniae in infants and children in the acute phase of Kawasaki disease was significantly higher than that of age-matched healthy controls ( P<0.01).
More Related Videos
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
07:42Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
Published on: October 13, 2015
Related Concept Videos
Bacterial Phylum Chlamydiae
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment